Class III · Low risk Terminated
Amlodipine besylate and Atorvastatin calcium tablets
Reason Subpotent drug
Is Pine recalled?
Yes — there is an active recall. 82 ongoing FDA recalls mention Pine (685 total). Check the affected lots below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Pine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed.
Class III · Low risk Terminated
Amlodipine besylate and Atorvastatin calcium tablets
Reason Subpotent drug
Class III · Low risk Terminated
Amlodipine besylate and Atorvastatin calcium tablets
Reason Subpotent drug
Class II · Moderate risk Terminated
Amlodipine Besylate Tablets
Reason CGMP Deviations: Firm did not adequately investigate customer complaints.
Class II · Moderate risk Terminated
Amlodipine Besylate Tablets
Reason CGMP Deviations: Firm did not adequately investigate customer complaints.
Class II · Moderate risk Terminated
Amlodipine Besylate Tablets
Reason CGMP Deviations: Firm did not adequately investigate customer complaints.
Class II · Moderate risk Terminated
Nitrofurantoin Monohydrate/Macrocrystals Capsules
Reason Failed Dissolution Specification; 6 month time point
Class II · Moderate risk Terminated
Nifedipine Extended-Release Tablets
Reason Failed Dissolution Specifications: High out of specification dissolution result at 1 hour time point.
Class I · High risk Terminated
EPINEPHrine HCl 4 mg added to 250 mL 0.9% Sodium Chloride Injection USP
Reason Presence of Particulate Matter: The firm produced products using 0.9% Sodium Chloride Injection, USP or 5% Dextrose Injection, USP which were subsequently recalled by the manufacturer due to the presence of particulate matter.
Class I · High risk Terminated
EPINEPHrine HCl 16 mg added to 250 mL 0.9% Sodium Chloride Injection USP
Reason Presence of Particulate Matter: The firm produced products using 0.9% Sodium Chloride Injection, USP or 5% Dextrose Injection, USP which were subsequently recalled by the manufacturer due to the presence of particulate matter.
Class I · High risk Terminated
EPINEPHrine HCl 1 mg added to 250 mL 0.9% Sodium Chloride Injection USP
Reason Presence of Particulate Matter: The firm produced products using 0.9% Sodium Chloride Injection, USP or 5% Dextrose Injection, USP which were subsequently recalled by the manufacturer due to the presence of particulate matter.
Class III · Low risk Terminated
Olanzapine
Reason Subpotent drug
Class III · Low risk Terminated
Olanzapine
Reason Subpotent drug
Class III · Low risk Terminated
Olanzapine
Reason Subpotent drug
Class II · Moderate risk Terminated
Amlodipine Besylate Tablets USP
Reason Failed tablet specifications: One lot was found to contain oversized tablets.
Class II · Moderate risk Terminated
Phen 15 mg - Topri 92 mg SR Cap
Reason Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.
Class II · Moderate risk Terminated
Hydrocortisone 1.6 mg/0.5 mL Susp
Reason Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.
Class II · Moderate risk Terminated
Nystatin 50
Reason Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.
Class II · Moderate risk Terminated
Coconut Oil Suppository
Reason Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.
Class II · Moderate risk Terminated
Cyclandelate 200 mg Caps
Reason Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.
Class II · Moderate risk Terminated
Triest 5 mg - Progest 150 mg Capsule
Reason Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.
Class II · Moderate risk Terminated
Colchicine 0.6 mg Caps
Reason Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.
Class II · Moderate risk Terminated
Lansoprazole 3 mg/mL Susp
Reason Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.
Class II · Moderate risk Terminated
Thymol 2% Solution
Reason Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.
Class II · Moderate risk Terminated
Methenamine/Phenyl Salicylate Capsule
Reason Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.